Buc Wheats
Buc Wheats was a brand of breakfast cereal produced by General Mills that was introduced in 1971 and discontinued in 1982. The cereal was notable for its wheat flakes combined with a distinctive maple-flavored coating, which set it apart from other cereals on the market at the time. Buc Wheats aimed to offer a hearty, nutritious option for breakfast, leveraging the natural appeal of whole grain wheat and the sweet, comforting taste of maple.
History[edit | edit source]
The introduction of Buc Wheats in the early 1970s was part of a broader trend in the breakfast cereal industry towards diversifying cereal flavors and ingredients. General Mills, a major player in the cereal market, developed Buc Wheats to capture the interest of consumers looking for a wholesome yet tasty breakfast option. The cereal's unique selling point was its maple-flavored coating, which was applied to the wheat flakes. This flavor profile was relatively novel for the time and helped Buc Wheats to carve out a niche within the competitive cereal market.
Despite a strong start and a dedicated fan base, Buc Wheats faced challenges in maintaining its market position. Changes in consumer preferences towards even healthier or alternatively flavored cereals and the introduction of numerous competing products eventually led to a decline in its popularity. In 1982, after a little more than a decade on the shelves, General Mills made the decision to discontinue Buc Wheats.
Product Description[edit | edit source]
Buc Wheats cereal consisted of whole grain wheat flakes. The flakes were notable for their crunchy texture and were coated with a sweet maple-flavored syrup. This combination of whole grain nutrition and sweet flavor was designed to appeal to both adults and children, making Buc Wheats a versatile breakfast option.
Legacy[edit | edit source]
Although Buc Wheats was discontinued, it has maintained a cult following among cereal enthusiasts who fondly remember its unique taste and texture. Discussions about Buc Wheats can still be found on various online forums and social media platforms, where fans reminisce about the cereal and sometimes campaign for its return. The cereal's legacy is a testament to the lasting impact that innovative flavors and marketing can have on consumer memory and brand loyalty.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD